Approved comparison material connected to this topic.
5 total recordsSource comparisons are presented without a generated winner.
Tesamorelin GHRH analog. Binds GHRH receptors on pituitary somatotrophs, stimulating GH synthesis and release 1–2mg once daily 30–45 min before first meal Primes pituitary for Ipamorelin's ghrelin-mimetic sign…
Tesamorelin + Ipamorelin Blend Dual GHRH + ghrelin receptor activation 250–500mcg twice daily subcutaneous High. 18–31% visceral fat reduction in 12-week trials Low cortisol/prolactin elevation, minimal water …
Before committing to this blend, understanding how it compares to single-agent protocols and alternative GH secretagogues clarifies why dual-pathway activation matters. Tesamorelin monotherapy GHRH receptor ag…
Protocol differences determine whether you achieve tissue-level anabolism or just transient hormonal changes. Tesamorelin 1mg solo 12–18 1.5–2 22–28 1.4–1.9 Sharp pulse, rapid clearance. Limited anabolic windo…
Weeks 1–4 (Titration) 1mg Tesamorelin + 200mcg Ipamorelin daily Fasted state, within 30min of waking, 90min pre-meal Minimal (tolerance phase) Injection site tolerance, transient water retention Establishes ba…